AJMC June 27, 2022
Two stakeholders involved in investment and development of behavioral care services discuss the potential of digital therapeutics as a cost-effective alternative to address unmet mental health needs during an AHIP 2022 session.
The rising mental health crisis in the United States has seen a substantial increase in demand and spending for behavioral care services, with an estimated 1 in 4 Americans prescribed medications to help them cope with stress, anxiety, or depression.
Despite market innovations, stakeholders of a session at AHIP 2022 discussed how the fragmented mental health care system continues to perpetuate barriers to care (cost, accessibility, stigma, etc) and prevent patients nationwide from getting the care they need. The role of prescription digital therapeutics (PDTs) was further addressed...
Today's Sponsors
Today's Sponsor